videoDetails)

Bharat Biotech: Providing Covaxin for ₹150/dose to the govt is not possible in the long run
)
Covaxin, the Coronavirus vaccine, maker Bharat Biotech on Tuesday said the price of Covaxin supplied to the Indian government at ₹150 per dose is a non-competitive price and is not sustainable in the long run and requires a higher price to offset part of the cost.